Code of Maryland Regulations
Title 10 - MARYLAND DEPARTMENT OF HEALTH
Part 3
Subtitle 14 - CANCER CONTROL
Chapter 10.14.01 - Cancer Registry
Section 10.14.01.02 - Incorporation by Reference
Universal Citation: MD Code Reg 10.14.01.02
Current through Register Vol. 51, No. 19, September 20, 2024
A. In this chapter, the following terms have the meanings indicated.
B. Terms Defined.
(1) "Assisted living program" has the meaning
stated in COMAR
10.07.14.02B.
(2) "Cancer registry" means a
computerized system to register all cases of reportable human cancer or
reportable human central nervous system (CNS) tumors of Maryland residents and
nonresidents diagnosed or treated in Maryland.
(3) "Cancer report" means a one-time abstract
from one or more of the following documents maintained by a reporting facility,
nursing facility, assisted living program, or general hospice care program of
each new case of reportable human cancer or CNS tumor diagnosed or treated, and
any other case of reportable human cancer or CNS tumor initially diagnosed or
treated for time periods as designated by the Secretary:
(a) Medical record;
(b) Pathology report; and
(c) Radiological report.
(4) Case of a Reportable Human CNS Tumor.
(a) "Case of a reportable human CNS tumor"
means an identified human tumor, irrespective of histologic type or behavior,
occurring as a primary tumor in any of the following sites or subsites with
International Classification of Diseases for Oncology, Third Edition (ICD-O-3)
topography codes C70.0-C72.9 and C75.1-C75.3:
(i) The brain;
(ii) The meninges;
(iii) The spinal cord;
(iv) The cauda equina;
(v) A cranial nerve;
(vi) The pituitary gland;
(vii) The pineal gland; or
(viii) The craniopharyngeal duct.
(b) "Case of a reportable human
CNS tumor" includes all benign and uncertain behavior tumors of the CNS
(ICD-iO-CM Codes D18.02, D32.0-D33.9, D35.2-D35.4, D42.0-D43.9, D44.3-D44.5,
Q85.00-Q85.09 and D 49.6, and all tumors of the CNS of benign and uncertain
behavior with ICD-O-3 codes of "0" or "1"), which includes codes from:
(i) The International Classification of
Diseases, Tenth Revision, Clinical Modification (ICD-10-CM); and
(ii) The International Classification of
Diseases for Oncology, Third Edition (ICD-O-3).
(5) "Case of reportable human cancer" means
the identification of a human cancer from the following list, which includes
codes from the International Classification of Diseases, Tenth Revision,
Clinical Modification (ICD-10-CM) and the International Classification of
Diseases for Oncology, Third Edition (ICD-O-3):
(a) All malignant neoplasms with ICD-10-CM
Codes C00-C43.9, C44.00, C44.09, C44.10_, C44.19_, C44.20_, C44.29_, C44.30_,
C44.39_, C44.40, C44.49, C44.50_, C44.59_, C44.60_, C44.69_, C44.70_, C44.79_,
C44.80, C44.89, C44.90, C44.99, C45._-C96._, or with ICD-O-3 behavior code of
"3", including genital skin cancer of the vagina, clitoris, vulva, prepuce,
penis, and scrotum and excluding other sites of skin cancer with ICD-O-3
topography codes C44.0-C44.9 with one of the following ICD-O-3 histologies:
(i) M-8000-8005 Neoplasms, malignant, not
otherwise specified of skin;
(ii)
M-8010-8046 Epithelial carcinomas of skin;
(iii) M-8050-8084 Papillary and squamous cell
carcinomas of skin (C44.02, C44.12_, C44.22_, C44.32_, C44.42, C44.52_,
C44.62_, C44.72_, C44.82, C44.92); or
(iv) M-8090-8110 Basal cell carcinomas
(C44.01, C44.11_, C44.21_, C44.31_, C44.41, C44.51_, C44.61_, C44.71_, C44.81,
C44.91);
(b) All
malignant neoplasms with the following ICD-10-CM codes where ICD-O-3 behavior
is "3" and ICD-O-3 histologies are reported except as follows:
(i) If there is evidence of multiple foci,
lymph node involvement, or metastasis, C37-Thymoma (M-8580);
(ii) C7A.020-Malignant carcinoid tumor of the
appendix (M-8240);
(iii) C54.1-Endometrial stroma, low grade
(M-8931);
(iv) If there is evidence
of multiple foci, lymph node involvement, or metastasis, D48.1-Stromal Tumor of
the digestive system (GIST 8639);
(v) D48.60-Phylloides
tumor (M-9020);
(vi) D45-Polycythema (M-9950);
(vii) D47.Z9-Plasmacytoma (M-9731, M-9734);
(viii) D4 7.3-Essential thrombocythemia (M-9962),
D46.0, D46.1, D46.20, D46.21, D46A, D46B-Low grade myelodysplastic syndrome
lesions (M-9980), D46.22-High grade myelodysplastic syndrome lesions (M-9983),
D46.C-Myelodysplastic syndrome with 5q deletion (M-9986), D469-Myelodysplastic
syndrome, unspecified (M-9975), D47.1-Myelofibrosis with myeloid metaplasia
(primary myelofibrosis) (M-9961), D47.Z1-post-transplant lymphoproliferative
disorder (M-9989), C94.40, C94.41, C94.42, D47.9, D47.Z9-lympho and
myeloproliferative disease (M-9960, M-9970);
(ix) C88.2-Alpha and
gamma heavy chain disease (M-9762) or Franklin disease (M-9763);
(x)
C88.0-Waldenstrom macroglobulinemia (M-9761);
(xi)
D46.4-Refractory anemia (M-9980); or
(xii)
D46.1-Refractory anemia with ringed sideroblasts (M-9982), refractory anemia
with excess blasts (M-9983), or refractory anemia with excess blasts in
transformation (M-9984);
(c) All cases of carcinoma in situ with
ICD-10-CM Codes D00._-D09.9, D47.Z2, D49.511- D49.519, D49.59, D78.31-D78.34,
and D89.40-D89.49, or with ICD-O-3 behavior code of "2", including genital skin
cancers of the vagina, clitoris, vulva, prepuce, penis, and scrotum and
excluding other skin cancers with ICD-O-3 topography codes C44.0_-C44.9_ with
one of the following ICD-O-3 histologies:
(i)
M-8000-8005 Neoplasms, malignant, not otherwise specified of skin;
(ii) M-8010-8046 Epithelial carcinomas of
skin;
(iii) M-8050-8084 Papillary
and squamous cell carcinomas of skin; and
(iv) M-8090-8110 Basal cell carcinomas;
or
(d) All cases of
intraepithelial neoplasia with ICD-O-3 histology code of M-8077/2:
(i) Including squamous intraepithelial
neoplasia of the larynx (LIN), vagina (VAIN), vulva (VTN), and anus (AIN)
(ICD-10-CM codes D02.0, D07.2, D07.1, and D01.3; and ICD-O-3 topography codes
C52, C51, and C21.J; and
(ii)
Excluding squamous intraepithelial neoplasia of the cervix (CIN III) and
glandular intraepithelial neoplasia of the prostate (PIN) (ICD-10-CM codes
D06._ and D07.5; and ICD-O-3 topography codes C53 and C61.9).
(6) "Computerized file"
means an electronic data file using software approved for use by the Secretary,
containing complete cancer report information transferable to a master
electronic database system maintained by the Department.
(7) "Department" means the Department of
Health and Mental Hygiene or a designee.
(8) "Freestanding ambulatory care facility"
has the meaning stated in Health-General Article, § 19-3 B-01, Annotated
Code of Maryland.
(9) "Freestanding
laboratory" means a facility, place, establishment, or institution which
performs a laboratory examination for a person, authorized by law to request
the examination, in connection with the diagnosis of a reportable human cancer
or CNS tumor, and is licensed by the State pursuant to COMAR 10.10.03, and:
(a) Not under the administrative control of a
hospital; or
(b) Under the
administrative control of a hospital for a diagnosis of reportable human cancer
or CNS tumor of a nonhospitalized patient.
(10) "General hospice care program" has the
meaning stated in COMAR
10.07.21.02B.
(11) "Hospital" means a facility
which is licensed by the State pursuant to COMAR 10.07.01.
(11-1) "Maryland Cancer Registry Data Use Manual and Procedures" means the document that describes the Maryland cancer registry procedures for release of cancer data and that outlines the procedures to obtain both non-confidential aggregate data and confidential individual-level data.
(12) "Nursing
facility" has the meaning stated in COMAR
10.07.02.01B.
(13) "Physician" means an
individual who:
(a) Practices medicine, as
defined in Health Occupations Article, §14-101, Annotated
Code of Maryland; and
(b) Diagnoses
or treats a case of reportable human cancer or a reportable human CNS tumor at
a practice located in Maryland.
(14) "Reporting facility" means any of the
following:
(a) A hospital, freestanding
laboratory, freestanding ambulatory care facility, or therapeutic radiological
center; or
(b) A physician who has
care of or has diagnosed a case of reportable human cancer or reportable human
CNS tumor for a nonhospitalized patient not otherwise reported.
(15) "Secretary" means the
Secretary of Health and Mental Hygiene or a designee of the
Secretary.
(16) "Therapeutic
radiological center" means a facility or institution:
(a) Performing radiological treatment for a
person authorized by law to request the treatment in connection with a
reportable human cancer or a reportable human CNS tumor; and
(b) Licensed or registered by the State
pursuant to COMAR 10.05.03 and not under the administrative control of a
hospital.
Disclaimer: These regulations may not be the most recent version. Maryland may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
